Ibuprofen Suppositories Administration in Infants and Children
Information source: Soroka University Medical Center
Information obtained from ClinicalTrials.gov on October 19, 2009
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Fever
Intervention: ibuprofen suppositories (Drug)
Phase: Phase 4
Status: Not yet recruiting
Sponsored by: Soroka University Medical Center Overall contact:
EUGENE LEIBOVITZ, MD, Phone: 972-8-6244065, Email: eugenel@bgu.ac.il
Summary
The study will evaluate the efficacy of Ibuprofen administered as suppositories in the
treatment of fever in infants and children. Ibuprofen as suppositories is not yet registered
in Israel, although widely used in Europe.
Clinical Details
Official title: Ibuprofen Suppositories Administration for Fever Treatment in Infants and Children
Study design: Treatment, Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study
Primary outcome: Fever decrease
Detailed description:
The drug will be used in 100 consecutive infants and children admitted with fever at the
pediatric ER of the Soroka Medical Center. The information on the drug efficacy will be
collected in appropriate parental questionnaires.
Eligibility
Minimum age: 6 Months.
Maximum age: 12 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Infants and children with rectal temperature > 38. 5 C
Exclusion Criteria:
- Infants < 6 months of age
Locations and Contacts
EUGENE LEIBOVITZ, MD, Phone: 972-8-6244065, Email: eugenel@bgu.ac.il
pediatric emergency room, SOROKA MEDICAL CENTER, BEER SHEVA, Israel
pediatric emergency room, SOROKA MEDICAL CENTER, BEER SHEVA, Israel
Additional Information
Starting date: July 2009
Ending date: December 2009
Last updated: July 21, 2009
|
